These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8159813)

  • 1. Setting health-protective soil concentrations for dermal contact allergens: a proposed methodology.
    Horowitz SB; Finley BL
    Regul Toxicol Pharmacol; 1994 Feb; 19(1):31-47. PubMed ID: 8159813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using human sweat to extract chromium from chromite ore processing residue: applications to setting health-based cleanup levels.
    Horowitz SB; Finley BL
    J Toxicol Environ Health; 1993 Dec; 40(4):585-99. PubMed ID: 8277520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe concentrations for dermal allergens in the environment.
    Nethercott JR; Finley B; Horowitz S; Paustenbach D
    N J Med; 1994 Oct; 91(10):694-7. PubMed ID: 7800281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the allergic contact dermatitis hazard posed by chromium-contaminated soil: identifying a "safe" concentration.
    Paustenbach DJ; Sheehan PJ; Paull JM; Wisser LM; Finley BL
    J Toxicol Environ Health; 1992 Sep; 37(1):177-207. PubMed ID: 1522610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the human health risks posed by exposure to chromium-contaminated soils.
    Sheehan PJ; Meyer DM; Sauer MM; Paustenbach DJ
    J Toxicol Environ Health; 1991 Feb; 32(2):161-201. PubMed ID: 1995927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of chromium allergy in the United States and its implications for setting soil cleanup: a cost-effectiveness case study.
    Proctor DM; Fredrick MM; Scott PK; Paustenbach DJ; Finley BL
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):27-37. PubMed ID: 9784430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the adequacy of maximum contaminant levels as health-protective cleanup goals: an analysis based on Monte Carlo techniques.
    Finley BL; Scott P; Paustenbach DJ
    Regul Toxicol Pharmacol; 1993 Dec; 18(3):438-55. PubMed ID: 8128005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexavalent chromium-contaminated soils: options for risk assessment and risk management.
    Felter SP; Dourson ML
    Regul Toxicol Pharmacol; 1997 Feb; 25(1):43-59. PubMed ID: 9056500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of chromium induced allergic contact dermatitis with 54 volunteers: implications for environmental risk assessment.
    Nethercott J; Paustenbach D; Adams R; Fowler J; Marks J; Morton C; Taylor J; Horowitz S; Finley B
    Occup Environ Med; 1994 Jun; 51(6):371-80. PubMed ID: 8044228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment of the allergic dermatitis potential of environmental exposure to hexavalent chromium.
    Finley BL; Paustenbach DJ; Nethercott J; Fowler J
    J Toxicol Environ Health; 1995 Mar; 44(3):377-83. PubMed ID: 7897698
    [No Abstract]   [Full Text] [Related]  

  • 11. Skin application of glutathione and iron sulfate can inhibit elicitation of allergic contact dermatitis from hexavalent chromium.
    Lejding T; Engfeldt M; Bruze M; Isaksson M; Svedman C; Zimerson E; Verma K; Mowitz M
    Contact Dermatitis; 2020 Jan; 82(1):45-53. PubMed ID: 31584201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact allergenic potency: correlation of human and local lymph node assay data.
    Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
    Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational dermatoses in health care workers evaluated for suspected allergic contact dermatitis.
    Suneja T; Belsito DV
    Contact Dermatitis; 2008 May; 58(5):285-90. PubMed ID: 18416759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cobalt-containing alloys and their ability to release cobalt and cause dermatitis.
    Julander A; Hindsén M; Skare L; Lidén C
    Contact Dermatitis; 2009 Mar; 60(3):165-70. PubMed ID: 19260915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatological toxicity of hexavalent chromium.
    Shelnutt SR; Goad P; Belsito DV
    Crit Rev Toxicol; 2007 Jun; 37(5):375-87. PubMed ID: 17612952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact dermatitis in the textile industry: a review of 72 patients.
    Soni BP; Sherertz EF
    Am J Contact Dermat; 1996 Dec; 7(4):226-30. PubMed ID: 8955486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of previously patch-tested patients referred to a contact dermatitis clinic.
    Soni BP; Sherertz EF
    Am J Contact Dermat; 1997 Mar; 8(1):10-4. PubMed ID: 9066841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patch tests in children with suspected allergic contact dermatitis: a prospective study and review of the literature.
    de Waard-van der Spek FB; Oranje AP
    Dermatology; 2009; 218(2):119-25. PubMed ID: 18946202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact allergy to colophony. Clinical and experimental studies with emphasis on clinical relevance.
    Färm G
    Acta Derm Venereol Suppl (Stockh); 1998; 201():1-42. PubMed ID: 9833065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment of the allergic dermatitis potential of environmental exposure to hexavalent chromium.
    Stern AH; Bagdon RE; Hazen RE; Marzulli FN
    J Toxicol Environ Health; 1993 Dec; 40(4):613-41. PubMed ID: 8277522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.